Literature DB >> 24451214

Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.

Sumeet Thareja1, Jonathan S Zager, Divya Sadhwani, Shalini Thareja, Ren Chen, Suroosh Marzban, Drazen M Jukic, Lewis F Glass, Jane Messina.   

Abstract

Studies have suggested that elevated tumor mitotic rate (MR) is linked to overall survival in thin melanoma. Recently, promising data regarding anti-phosphohistone 3 (pHH3) immunohistochemistry and its ability to aid in calculation of MR have emerged. The authors retrospectively analyzed original biopsies from 13 thin melanomas with positive sentinel node (SN) status and 16 thin melanomas with negative SN status. Both anti-pHH3 immunohistochemistry and the hematoxylin and eosin (H&E) stain were used to evaluate MR by 2 dermatopathologists blinded to SN status using the "hot spot" method. Intraclass coefficient values were attained to measure interobserver concordance and reliability of the pHH3 stain. By generating a receiver operating characteristic curve and analyzing the overall area under the curve, pHH3 was found to have good interobserver reliability. The relationship between MR and SN involvement was also evaluated, but this correlation was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24451214      PMCID: PMC5764097          DOI: 10.1097/DAD.0b013e31829433b6

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  18 in total

1.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Authors:  John F Thompson; Seng-Jaw Soong; Charles M Balch; Jeffrey E Gershenwald; Shouluan Ding; Daniel G Coit; Keith T Flaherty; Phyllis A Gimotty; Timothy Johnson; Marcella M Johnson; Stanley P Leong; Merrick I Ross; David R Byrd; Natale Cascinelli; Alistair J Cochran; Alexander M Eggermont; Kelly M McMasters; Martin C Mihm; Donald L Morton; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Authors:  Vernon K Sondak; Jeremy M G Taylor; Michael S Sabel; Yue Wang; Lori Lowe; Amelia C Grover; Alfred E Chang; Alan M Yahanda; James Moon; Timothy M Johnson
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

3.  Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Authors:  Susan B Kesmodel; Giorgos C Karakousis; Jeffrey D Botbyl; Robert J Canter; Robert T Lewis; Peter M Wahl; Kyla P Terhune; Abass Alavi; David E Elder; Michael E Ming; DuPont Guerry; Phyllis A Gimotty; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Journal:  Ann Surg Oncol       Date:  2005-04-19       Impact factor: 5.344

4.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

5.  Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.

Authors:  J D Wagner; M S Gordon; T Y Chuang; J J Coleman; J T Hayes; S H Jung; C Love
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

6.  Recent trends in cutaneous melanoma incidence among whites in the United States.

Authors:  A Jemal; S S Devesa; P Hartge; M A Tucker
Journal:  J Natl Cancer Inst       Date:  2001-05-02       Impact factor: 13.506

7.  Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.

Authors:  Phyllis A Gimotty; DuPont Guerry; Michael E Ming; Rosalie Elenitsas; Xiaowei Xu; Brian Czerniecki; Francis Spitz; Lynn Schuchter; David Elder
Journal:  J Clin Oncol       Date:  2004-08-09       Impact factor: 44.544

8.  Lethal "thin" malignant melanoma. Identifying patients at risk.

Authors:  C L Slingluff; R T Vollmer; D S Reintgen; H F Seigler
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

9.  Predictors of regional nodal disease in patients with thin melanomas.

Authors:  Giorgos C Karakousis; Phyllis A Gimotty; Jeffrey D Botbyl; Susan B Kesmodel; David E Elder; Rosalie Elenitsas; Michael E Ming; DuPont Guerry; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Journal:  Ann Surg Oncol       Date:  2006-03-07       Impact factor: 5.344

Review 10.  Sentinel lymph node biopsy for melanoma: indications and rationale.

Authors:  Giao Q Phan; Jane L Messina; Vernon K Sondak; Jonathan S Zager
Journal:  Cancer Control       Date:  2009-07       Impact factor: 3.302

View more
  4 in total

1.  Using global gene expression to discriminate thin melanomas with poor outcomes.

Authors:  Zachary Hothem; Andrew Bayci; Bryan J Thibodeau; Billie E Ketelsen; Laura E Fortier; Alison F Uzieblo; Diane Cosner; Kristin Totoraitis; Richard D Keidan; George D Wilson
Journal:  Mol Cell Oncol       Date:  2016-11-08

2.  Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Authors:  Eleonora Duregon; Adele Cassenti; Alessandra Pittaro; Laura Ventura; Rebecca Senetta; Roberta Rudà; Paola Cassoni
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

3.  Dual Immunohistochemical Detection of Mitoses in Melanoma.

Authors:  Thomas M Soike; John C Maize; Jonathan S Ralston; Benjamin Hayes; Julie Swick
Journal:  Pathol Oncol Res       Date:  2017-02-12       Impact factor: 3.201

4.  Vascular remodeling underlies rebleeding in hemophilic arthropathy.

Authors:  Vikas Bhat; Merissa Olmer; Shweta Joshi; Donald L Durden; Thomas J Cramer; Richard Fw Barnes; Scott T Ball; Tudor H Hughes; Mauricio Silva; James V Luck; Randy E Moore; Laurent O Mosnier; Annette von Drygalski
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.